Based on the provided data, here's my analysis of whether to buy or sell NDAQ stock:
Technical Analysis
The stock is currently trading at $81.25, showing a modest gain of +0.15% in the regular market session. The stock is trading above its 20-day moving average of $78.17 and 60-day moving average of $78.73, indicating a short-term upward trend. The RSI-14 reading of 63.42 suggests the stock is approaching but not yet in overbought territory.
Recent Events & News According to recent news, Nasdaq and BCG released a report highlighting potential $25-50 billion efficiency gains in banks' Risk and Compliance functions. This strategic initiative could create new revenue opportunities for Nasdaq's technology solutions business.
However, there was also a security incident where Nasdaq's official X account was compromised, though this appears to be an isolated event with minimal impact on operations.
Analyst Consensus Recent analyst ratings show a generally positive outlook:
Recommendation Based on the technical setup, positive analyst sentiment, and strategic initiatives to drive growth, NDAQ stock appears positioned for further upside from current levels.
Based on the provided data and market context, here's the price prediction for NDAQ stock in 2025:
NDAQ stock is expected to reach $95-100 by end of 2025, representing a potential upside of 17-23% from current price of $81.15. This projection is supported by the company's strong position in IPO market leadership and technological innovations in AI-driven market solutions.
The key growth driver will be Nasdaq's expansion in Risk and Compliance technology solutions, which could generate $25-50 billion in efficiency gains for banks. Additionally, Nasdaq maintained its leadership in healthcare, technology, and biotech IPOs with a record-breaking 171 IPOs in 2024, signaling optimism for a robust IPO market in 2025.
The stock currently trades at reasonable valuations with RSI of 63.42 indicating moderate momentum without being overbought. Technical analysis shows key fibonacci resistance levels at $82.34 and $84.72, which could act as intermediate targets before reaching the year-end price target.
The S1 support level for NDAQ Stock is $76.1 ,The R1 resistant level for NDAQ Stock is $80.86.
As of the end of day on 2025-01-24, the price of NDAQ Stock was $81.25.
The target price for NDAQ Stock according to analyst rating is 87.77, with the highest price target at 98.00 and the lowest at 75.00. Analysts have a Strong Buy rating on NDAQ Stock overall.
The market cap of NDAQ is $46.6B.
Based on the provided financial data and recent news, here's a concise analysis of NDAQ's valuation:
Valuation Analysis NDAQ appears fairly valued to slightly overvalued based on several key metrics:
Financial Performance
Recent Developments
Conclusion NDAQ appears overvalued at current levels due to:
Nasdaq, Inc. is a global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the financial system. The Company manages, operates, and provides its products and services in three business segments: Capital Access Platforms, Financial Technology and Market Services. The Company's Capital Access Platforms segment includes Data & Listing Services, Index and Workflow & Insights. The Company's Financial Technology segment comprises of Financial Crime Management Technology, Regulatory Technology and Capital Markets Technology solutions. The Company's Market Services segment operates multiple exchanges and other marketplace facilities across several asset classes, including derivatives, commodities, cash equity, debt, structured products, and exchange-traded products (ETPs). The Market Services segment also provides clearing, settlement, and central depository services.
Based on the provided data and market analysis, here's a projection for NDAQ stock price in 2030:
NASDAQ Inc. (NDAQ) stock is projected to reach $135-140 by 2030, representing a ~66-72% increase from current levels around $81. This forecast is driven by the company's strategic expansion in risk and compliance technology solutions that could unlock $25-50 billion in efficiency gains for banks, as well as its growing role in the evolving financial technology landscape.
The growth trajectory is supported by NDAQ's strong market position in IPO listings and technological innovation, with the exchange maintaining leadership in healthcare, technology, and biotech IPOs. Additionally, the company's investments in AI and cloud infrastructure position it well for future market opportunities.
NDAQ has a total of 8525 employees.